1. alein99
2. dddimensions
3. jjhale69
4. robflutie
5. jakuwladi
1.alein99 01/22/2018
$85 million of its common stock
2.robflutie 10/01/2017
Noble Financial resumes at Buy. When the company releases positive phase 2b results on MS study, the stock is heading up to the next level. They are trying to bore us right now...
3.dddimensions 10/01/2017
I think this drug has a good chance to make it. EMERYVILLE, Calif., Sept. 07, 2017-- Adamas Pharmaceuticals, Inc. today announced positive topline data from the Phase 1 b clinical trial of ADS-4101
4.jjhale69 02/08/2018
Tempting!
5.dddimensions 01/22/2018
Adamas Announces Proposed Public Offering of Common Stock
6.rodina9046 04/04/2018
Leerink Partners initiates as an outperform, $31PT
7.jjhale69 01/23/2018
Anyone seen this news? PT $48
8.jakuwladi 02/20/2018
No anger at all...I rest well at night... this is a long term hold for me
9.jjhale69 01/26/2018
Prices 3 mln shares of common stock at $41.50 per share
10.alein99 10/01/2017
Adamas' Parkinson's Drug Cost Is Double Analyst Expectations
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW